Brief: Somalogic Q2 revenue USD 16.597 million
14/08/2023 23:22
Aug 14 (Reuters) - Somalogic Q2 net income USD -24.772 million. * Q2 basic EPS USD -0.13 * Q2 revenue USD 16.597 million * Q2 gross margin 45.4% * Q2 adjusted EBITDA USD -28.9 million
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders